Significant disparities in the quality of end-of-life lung cancer care were found among racial-ethnic minorities, with higher odds of experiencing potentially preventable medical encounters during end-of-life as compared with non-Hispanic whites.
Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation (RT) alone.
Lung Cancer Clinical Trial Eligibility Criteria and Requirements Have Increased in Number and Complexity
Eligibility criteria continue to increase in number and complexity for lung cancer clinical trials.
DENVER – Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication of “Scientific Advances in Thoracic Oncology,” available online now and in the August 2017 issue of the IASLC’s Journal of Thoracic Oncology (JTO).
DENVER – Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.